VRNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $188,928.00

Insider Selling (Last 12 Months): $30,467,568.32

Verona Pharma PLC American Depositary Share Insider Trading History Chart

Verona Pharma PLC American Depositary Share Share Price & Price History

^$104.74

▼ -0.03 (-0.03%)

As of 07/16/2025 05:00 PM ET

Days: 30 | 90 | 365

Verona Pharma PLC American Depositary Share Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2025	Andrew Fisher	General Counsel	Sell	80,000	$11.53	$922,400.00	359,999
6/11/2025	David Zaccardelli	CEO	Sell	400,000	$11.40	$4,560,000.00	13,190,168
6/11/2025	Mark W. Hahn	CFO	Sell	400,000	$11.40	$4,560,000.00	12,278,992
5/29/2025	David Zaccardelli	CEO	Sell	208,696	$9.33	$1,947,133.68	13,590,168
5/29/2025	Mark W. Hahn	CFO	Sell	204,864	$9.33	$1,911,381.12	12,678,992
5/28/2025	David Zaccardelli	CEO	Sell	157,704	$9.30	$1,466,647.20	13,798,864
5/28/2025	Mark W. Hahn	CFO	Sell	162,704	$9.30	$1,513,147.20	12,883,856
5/27/2025	David Zaccardelli	CEO	Sell	33,600	$9.53	$320,208.00	13,956,568
5/27/2025	Mark W. Hahn	CFO	Sell	32,432	$9.53	$309,076.96	13,046,560
5/6/2025	Kathleen A. Rickard	Insider	Sell	114,984	$8.82	$1,014,158.88	2,546,472
4/29/2025	Andrew Fisher	General Counsel	Sell	26,072	$8.98	$234,126.56	359,993
4/29/2025	David Zaccardelli	CEO	Sell	90,360	$8.98	$811,432.80	14,377,176
4/29/2025	Kathleen A. Rickard	Insider	Sell	34,384	$8.98	$308,768.32	2,660,656
4/29/2025	Vikas Sinha	Director	Sell	20,000	$8.92	$178,400.00	74,440
3/12/2025	Kathleen A. Rickard	Insider	Sell	79,264	$8.35	$661,854.40	2,608,976
12/6/2024	David Zaccardelli	CEO	Sell	162,800	$5.01	$815,628.00	14,204,752
12/6/2024	Mark W. Hahn	CFO	Sell	183,728	$5.01	$920,477.28	13,293,736
12/4/2024	David Zaccardelli	CEO	Sell	67,608	$5.00	$338,040.00	15,007,816
12/4/2024	Mark W. Hahn	CFO	Sell	58,184	$5.00	$290,920.00	14,117,512
12/2/2024	David Zaccardelli	CEO	Sell	3,200	$5.00	$16,000.00	15,075,424
12/2/2024	Mark W. Hahn	CFO	Sell	1,600	$5.00	$8,000.00	14,175,696
11/29/2024	David Zaccardelli	CEO	Sell	98,888	$5.01	$495,428.88	15,078,624
11/29/2024	Mark W. Hahn	CFO	Sell	98,704	$5.01	$494,507.04	14,177,296
11/27/2024	David Zaccardelli	CEO	Sell	23,240	$5.00	$116,200.00	15,177,512
11/27/2024	Mark W. Hahn	CFO	Sell	12,936	$5.00	$64,680.00	14,276,000
11/25/2024	Kathleen A. Rickard	Insider	Sell	240,000	$4.90	$1,176,000.00	2,671,480
11/25/2024	Mark W. Hahn	CFO	Sell	1,600	$5.00	$8,000.00	14,289,736
11/11/2024	David Zaccardelli	CEO	Sell	2,400	$5.00	$12,000.00	15,202,352
11/6/2024	David R. Ebsworth	Director	Buy	39,360	$4.80	$188,928.00	920,003
11/4/2024	David Zaccardelli	CEO	Sell	94,144	$4.39	$413,292.16	15,204,752
11/4/2024	Mark W. Hahn	CFO	Sell	80,784	$4.39	$354,641.76	14,293,736
11/1/2024	David Zaccardelli	CEO	Sell	46,888	$4.38	$205,369.44	15,298,896
11/1/2024	Mark W. Hahn	CFO	Sell	48,888	$4.38	$214,129.44	14,374,520
10/25/2024	David Zaccardelli	CEO	Sell	4,800	$4.38	$21,024.00	14,591,736
10/24/2024	Mark W. Hahn	CFO	Sell	141,360	$4.38	$619,156.80	13,672,560
10/23/2024	David Zaccardelli	CEO	Sell	16	$4.38	$70.08	14,736,536
10/21/2024	David Zaccardelli	CEO	Sell	110,456	$4.38	$483,797.28	14,894,464
10/21/2024	Mark W. Hahn	CFO	Sell	116,696	$4.38	$511,128.48	13,973,264
10/18/2024	David Zaccardelli	CEO	Sell	245,784	$4.38	$1,076,533.92	15,004,920
10/18/2024	Mark W. Hahn	CFO	Sell	249,728	$4.38	$1,093,808.64	14,089,960
5/3/2024	Kathleen A. Rickard	Insider	Sell	36,248	$1.96	$71,046.08	2,621,552
11/20/2023	Martin Edwards	Director	Buy	33,736	$1.84	$62,074.24	144,800
11/6/2023	David R. Ebsworth	Director	Buy	160,000	$1.98	$316,800.00	844,643
11/3/2023	Kathleen A. Rickard	Insider	Sell	58,752	$1.92	$112,803.84	2,840,640
8/7/2023	Claire Poll	General Counsel	Sell	1,512	$2.47	$3,734.64	1,907,367
8/7/2023	David Zaccardelli	CEO	Sell	8,616	$2.47	$21,281.52	16,431,800
8/7/2023	Kathleen A. Rickard	Insider	Sell	1,600	$2.47	$3,952.00	2,872,528
8/4/2023	David Zaccardelli	CEO	Sell	150,000	$2.50	$375,000.00	16,440,416
8/3/2023	Claire Poll	General Counsel	Sell	20,608	$2.54	$52,344.32	1,935,231
8/3/2023	Kathleen A. Rickard	Insider	Sell	50,600	$2.55	$129,030.00	2,902,072
8/3/2023	Mark W. Hahn	CFO	Sell	117,272	$2.54	$297,870.88	15,679,864
8/2/2023	David Zaccardelli	CEO	Sell	73,704	$2.59	$190,893.36	16,707,688
8/1/2023	Claire Poll	General Counsel	Sell	18,608	$2.68	$49,869.44	1,968,783
8/1/2023	Kathleen A. Rickard	Insider	Sell	19,736	$2.68	$52,892.48	2,966,400
8/1/2023	Mark W. Hahn	CFO	Sell	105,944	$2.68	$283,929.92	15,870,840
5/15/2023	Orbimed Advisors Llc	Director	Sell	359,713	$20.08	$7,223,037.04	3,777,778
5/11/2023	Orbimed Advisors Llc	Director	Sell	80,000	$22.26	$1,780,800.00	4,180,691
5/3/2023	Kathleen A. Rickard	Insider	Sell	28,752	$2.65	$76,192.80	2,971,136
5/1/2023	Claire Poll	General Counsel	Sell	80,376	$2.58	$207,370.08	1,979,063
5/1/2023	David Zaccardelli	CEO	Sell	455,536	$2.58	$1,175,282.88	16,887,336
5/1/2023	Kathleen A. Rickard	Insider	Sell	77,424	$2.58	$199,753.92	2,999,888
5/1/2023	Mark W. Hahn	CFO	Sell	455,528	$2.58	$1,175,262.24	15,976,784
2/1/2023	Claire Poll	General Counsel	Sell	152,000	$2.59	$393,680.00	774,256
2/1/2023	David Zaccardelli	CEO	Sell	432,928	$2.56	$1,108,295.68	17,342,872
2/1/2023	Kathleen A. Rickard	Insider	Sell	89,960	$2.56	$230,297.60	3,106,064
2/1/2023	Mark W. Hahn	CFO	Sell	413,168	$2.56	$1,057,710.08	16,432,312
12/22/2022	Claire Poll	General Counsel	Sell	240,000	$2.69	$645,600.00	774,256
12/22/2022	Orbimed Advisors Llc	Director	Sell	3,969,496	$21.77	$86,415,927.92	36,255,896
12/20/2022	David Zaccardelli	CEO	Sell	600,000	$2.12	$1,272,000.00	17,775,800
8/9/2022	David Zaccardelli	CEO	Sell	600,000	$1.75	$1,050,000.00	15,263,560
8/2/2022	Kathleen A. Rickard	Insider	Sell	28,752	$0.70	$20,126.40	2,376,040
8/1/2022	David Zaccardelli	CEO	Sell	32,904	$0.70	$23,032.80	15,863,560
8/1/2022	Mark W. Hahn	CFO	Sell	13,168	$0.70	$9,217.60	14,913,496

SEC Filings (Institutional Ownership Changes) for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA)

85.88% of Verona Pharma PLC American Depositary Share stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Verona Pharma PLC American Depositary Share Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/15/2025	Compagnie Lombard Odier SCmA	1,224	$0.12M	0.0%	N/A	0.001%
7/14/2025	GAMMA Investing LLC	1,940	$0.18M	0.0%	+5.6%	0.002%
7/14/2025	Atle Fund Management AB	47,100	$4.46M	1.9%	+35.8%	0.055%
7/11/2025	Farther Finance Advisors LLC	1,000	$95K	0.0%	N/A	0.001%
7/10/2025	NorthCrest Asset Manangement LLC	5,850	$0.54M	0.0%	-43.3%	0.007%
7/10/2025	Wealth Enhancement Advisory Services LLC	4,249	$0.39M	0.0%	N/A	0.005%
7/9/2025	Harbor Capital Advisors Inc.	15,774	$1.49M	0.1%	N/A	0.019%
6/18/2025	Voya Investment Management LLC	57,505	$3.65M	0.0%	-3.6%	0.071%
5/29/2025	Rhumbline Advisers	562	$36K	0.0%	-40.8%	0.001%
5/21/2025	Acadian Asset Management LLC	759	$48K	0.0%	N/A	0.001%
5/21/2025	Geneos Wealth Management Inc.	630	$40K	0.0%	+44.2%	0.001%
5/16/2025	Woodline Partners LP	300,827	$19.10M	0.1%	-41.8%	0.371%
5/16/2025	Octagon Capital Advisors LP	217,264	$13.79M	1.5%	-62.0%	0.268%
5/16/2025	Fred Alger Management LLC	15,489	$0.98M	0.0%	-46.5%	0.019%
5/16/2025	Goldman Sachs Group Inc.	1,041,408	$66.12M	0.0%	+274.5%	1.223%
5/16/2025	Temasek Holdings Private Ltd	31,684	$2.01M	0.0%	N/A	0.039%
5/16/2025	Scientech Research LLC	12,741	$0.81M	0.2%	N/A	0.016%
5/16/2025	Parkman Healthcare Partners LLC	260,421	$16.53M	2.0%	-63.9%	0.321%
5/16/2025	Polar Asset Management Partners Inc.	118,827	$7.54M	0.2%	N/A	0.147%
5/16/2025	NewEdge Advisors LLC	912	$58K	0.0%	N/A	0.001%
5/16/2025	Millennium Management LLC	323,545	$20.54M	0.0%	+69.0%	0.399%
5/16/2025	Duquesne Family Office LLC	1,002,080	$63.62M	2.1%	+12.9%	1.236%
5/16/2025	Eventide Asset Management LLC	2,893,437	$183.69M	3.7%	-7.6%	3.569%
5/16/2025	Cinctive Capital Management LP	65,375	$4.15M	0.3%	N/A	0.081%
5/16/2025	Cutter Capital Management LP	160,000	$10.16M	4.4%	N/A	0.197%
5/16/2025	Boothbay Fund Management LLC	473,929	$30.09M	0.8%	+9.7%	0.585%
5/16/2025	Allostery Investments LP	12,500	$0.79M	1.1%	N/A	0.015%
5/16/2025	Ally Bridge Group NY LLC	139,067	$8.83M	7.9%	N/A	0.172%
5/16/2025	Adage Capital Partners GP L.L.C.	1,631,000	$103.55M	0.2%	+381.9%	2.012%
5/16/2025	ADAR1 Capital Management LLC	20,000	$1.27M	0.2%	-31.3%	0.025%
5/15/2025	Vestal Point Capital LP	267,627	$16.99M	1.2%	-45.9%	0.330%
5/15/2025	Frazier Life Sciences Management L.P.	3,457,850	$219.54M	10.0%	+2.2%	4.265%
5/15/2025	Baker BROS. Advisors LP	223,843	$14.21M	0.2%	N/A	0.276%
5/15/2025	Maverick Capital Ltd.	1,783,498	$113.23M	2.0%	-43.0%	2.200%
5/15/2025	Royal Bank of Canada	9,719	$0.62M	0.0%	+43.3%	0.012%
5/15/2025	Point72 Europe London LLP	38,135	$2.42M	0.2%	-3.1%	0.047%
5/15/2025	Armistice Capital LLC	68,201	$4.33M	0.1%	N/A	0.084%
5/15/2025	Quarry LP	1,800	$0.11M	0.0%	N/A	0.002%
5/15/2025	Velan Capital Investment Management LP	95,000	$6.03M	6.2%	+90.0%	0.117%
5/15/2025	State of Wyoming	4,590	$0.29M	0.0%	N/A	0.006%
5/15/2025	Trexquant Investment LP	63,508	$4.03M	0.0%	+103.8%	0.078%
5/14/2025	Affinity Asset Advisors LLC	615,000	$39.05M	3.7%	-6.8%	0.759%
5/14/2025	FORA Capital LLC	5,107	$0.32M	0.0%	N/A	0.006%
5/14/2025	Jasper Ridge Partners L.P.	10,635	$0.68M	0.0%	N/A	0.013%
5/14/2025	Atika Capital Management LLC	208,134	$13.21M	1.9%	-1.8%	0.257%
5/14/2025	Price T Rowe Associates Inc. MD	1,866,280	$118.49M	0.0%	+1.8%	2.302%
5/14/2025	Candriam S.C.A.	297,755	$18.90M	0.1%	-32.4%	0.367%
5/14/2025	Wellington Management Group LLP	2,131,502	$135.33M	0.0%	-29.5%	2.629%
5/13/2025	American Century Companies Inc.	308,820	$19.61M	0.0%	-50.2%	0.381%
5/13/2025	Aisling Capital Management LP	615,352	$39.07M	13.5%	-44.8%	0.759%
5/13/2025	Lord Abbett & CO. LLC	924,798	$58.72M	0.2%	N/A	1.141%
5/13/2025	Tokio Marine Asset Management Co. Ltd.	10,997	$0.70M	0.0%	N/A	0.014%
5/13/2025	Caitong International Asset Management Co. Ltd	1,694	$0.11M	0.1%	N/A	0.002%
5/13/2025	Russell Investments Group Ltd.	87,402	$5.55M	0.0%	N/A	0.108%
5/13/2025	Rathbones Group PLC	8,218	$0.52M	0.0%	-19.6%	0.010%
5/12/2025	Knott David M Jr	88,000	$5.59M	2.6%	-44.8%	0.109%
5/12/2025	Aigen Investment Management LP	10,044	$0.64M	0.1%	N/A	0.012%
5/12/2025	Virtu Financial LLC	10,926	$0.69M	0.0%	N/A	0.013%
5/12/2025	Invesco Ltd.	3,296	$0.21M	0.0%	N/A	0.004%
5/12/2025	Townsquare Capital LLC	18,688	$1.19M	0.0%	+4.1%	0.023%
5/12/2025	Watchtower Advisors LP	145,338	$9.23M	6.7%	-38.6%	0.179%
5/12/2025	Vivo Capital LLC	1,438,785	$91.35M	12.1%	-37.0%	1.775%
5/9/2025	CenterBook Partners LP	9,480	$0.60M	0.0%	N/A	0.012%
5/9/2025	BIT Capital GmbH	5,407	$0.34M	0.0%	-83.0%	0.007%
5/8/2025	Baader Bank Aktiengesellschaft	6,870	$0.42M	0.0%	N/A	0.009%
5/8/2025	GSA Capital Partners LLP	20,526	$1.30M	0.1%	-61.5%	0.025%
5/8/2025	Federated Hermes Inc.	1,267,761	$80.49M	0.2%	-30.5%	1.569%
5/7/2025	LPL Financial LLC	50,533	$3.21M	0.0%	+68.3%	0.063%
5/7/2025	TD Asset Management Inc	229,742	$14.59M	0.0%	-4.0%	0.284%
5/6/2025	Cetera Investment Advisers	24,718	$1.57M	0.0%	+6.2%	0.031%
5/6/2025	Dorsey Wright & Associates	70,671	$4.49M	1.1%	-10.1%	0.087%
5/6/2025	1492 Capital Management LLC	99,327	$6.31M	3.4%	-0.7%	0.123%
5/6/2025	Wedbush Securities Inc.	3,160	$0.20M	0.0%	N/A	0.004%
5/6/2025	Advisors Preferred LLC	1,599	$94K	0.0%	+65.4%	0.002%
5/6/2025	Legato Capital Management LLC	25,731	$1.63M	0.2%	+3.5%	0.032%
5/6/2025	Y Intercept Hong Kong Ltd	11,350	$0.72M	0.0%	N/A	0.014%
5/6/2025	Pathway Capital Management LP	98,329	$6.24M	36.0%	N/A	0.122%
5/5/2025	GW&K Investment Management LLC	194,112	$12.32M	0.1%	-16.5%	0.240%
5/5/2025	Allianz Asset Management GmbH	15,800	$1M	0.0%	+6.8%	0.020%
5/5/2025	Teachers Retirement System of The State of Kentucky	18,389	$1.17M	0.0%	-9.3%	0.023%
5/5/2025	Atle Fund Management AB	34,690	$2.20M	1.0%	N/A	0.043%
5/5/2025	Diversify Advisory Services LLC	8,265	$0.53M	0.0%	+34.0%	0.010%
5/5/2025	Yeomans Consulting Group Inc.	3,802	$0.24M	0.1%	N/A	0.005%
5/5/2025	Jennison Associates LLC	1,261,153	$80.07M	0.1%	-33.3%	1.560%
5/2/2025	Burns Matteson Capital Management LLC	3,605	$0.23M	0.1%	N/A	0.004%
5/2/2025	Verdence Capital Advisors LLC	3,434	$0.22M	0.0%	N/A	0.004%
5/2/2025	Jacobson & Schmitt Advisors LLC	37,703	$2.39M	0.5%	-13.8%	0.047%
5/2/2025	TimesSquare Capital Management LLC	496,551	$31.53M	0.5%	N/A	0.614%
5/1/2025	Rice Hall James & Associates LLC	823,012	$52.25M	3.1%	-13.8%	1.018%
5/1/2025	New York State Common Retirement Fund	15,375	$0.98M	0.0%	+150.3%	0.019%
5/1/2025	Diversify Wealth Management LLC	29,338	$1.86M	0.1%	+13.9%	0.036%
4/30/2025	Alps Advisors Inc.	60,180	$3.82M	0.0%	-9.1%	0.074%
4/30/2025	M&T Bank Corp	4,669	$0.30M	0.0%	-10.9%	0.006%
4/30/2025	Values First Advisors Inc.	25,129	$1.59M	0.9%	+6.9%	0.031%
4/29/2025	Envestnet Asset Management Inc.	55,253	$3.51M	0.0%	-2.4%	0.068%
4/29/2025	Bank of New York Mellon Corp	108,835	$6.91M	0.0%	N/A	0.135%
4/29/2025	GF Fund Management CO. LTD.	9,764	$0.62M	0.0%	+528.7%	0.012%
4/29/2025	Moody Aldrich Partners LLC	96,603	$6.13M	1.3%	+1.7%	0.120%
4/28/2025	Vermillion Wealth Management Inc.	700	$44K	0.0%	-30.0%	0.001%
4/25/2025	Sumitomo Mitsui Trust Group Inc.	4,470	$0.28M	0.0%	N/A	0.006%

Data available starting January 2016

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.

Today's Range

Now: $104.74

$104.71

$104.91

50 Day Range

MA: $85.95

$63.36

$104.85

52 Week Range

Now: $104.74

$18.51

$104.99

Volume

6,941,561 shs

Average Volume

1,705,862 shs

Market Capitalization

$8.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24

Who are the company insiders with the largest holdings of Verona Pharma PLC American Depositary Share?: Verona Pharma PLC American Depositary Share's top insider shareholders include:
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
Claire Poll (General Counsel)
David R Ebsworth (Director)
Andrew Fisher (General Counsel)
Martin Edwards (Director)
Vikas Sinha (Director)
Learn More about top insider investors at Verona Pharma PLC American Depositary Share.
Who are the major institutional investors of Verona Pharma PLC American Depositary Share?: Verona Pharma PLC American Depositary Share's top institutional investors include:
Atle Fund Management AB — 0.06%
Harbor Capital Advisors Inc. — 0.02%
NorthCrest Asset Manangement LLC — 0.01%
Wealth Enhancement Advisory Services LLC — 0.01%
GAMMA Investing LLC — 0.00%
Compagnie Lombard Odier SCmA — 0.00%
Learn More about top institutional investors of Verona Pharma PLC American Depositary Share stock.
Which major investors are selling Verona Pharma PLC American Depositary Share stock?: Within the previous quarter, VRNA stock was sold by these institutional investors:
NorthCrest Asset Manangement LLC
Within the last year, company insiders that have sold Verona Pharma PLC American Depositary Share company stock include:
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
Claire Poll (General Counsel)
David R Ebsworth (Director)
Learn More investors selling Verona Pharma PLC American Depositary Share stock.
Which major investors are buying Verona Pharma PLC American Depositary Share stock?: In the last quarter, VRNA stock was bought by institutional investors including:
Harbor Capital Advisors Inc.
Atle Fund Management AB
Wealth Enhancement Advisory Services LLC
Compagnie Lombard Odier SCmA
Farther Finance Advisors LLC
GAMMA Investing LLC
Within the last year, these company insiders have bought Verona Pharma PLC American Depositary Share stock:
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Learn More investors buying Verona Pharma PLC American Depositary Share stock.